What are the recommended thiopental doses for induction and maintenance in pediatric patients (neonates, infants, and children)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Thiopental Pediatric Dosing

Intravenous Induction Dosing

For IV induction of anesthesia in pediatric patients, thiopental should be dosed at 5–8.5 mg/kg, with neonates requiring significantly lower doses (3.4 mg/kg) compared to infants 1–6 months (6.3 mg/kg) and older children (5–10.5 mg/kg depending on premedication status). 1, 2, 3

Age-Specific IV Dosing

  • Neonates (0–14 days): The ED50 for satisfactory induction is 3.4 mg/kg IV, which is significantly lower than older infants due to developmental pharmacokinetic differences. 2

  • Infants (1–6 months): The ED50 increases to 6.3 mg/kg IV for satisfactory induction without gross movements or coughing. 2

  • Children (unpremedicated): The ED90 is 10.5 mg/kg IV, which is substantially higher than in premedicated children. 3

  • Children (premedicated): The ED90 drops to 4.2–5.2 mg/kg IV depending on the premedication regimen used (trimeprazine-droperidol-physeptone combinations are most effective). 3

  • Emergency rapid-sequence induction: A dose of 5 mg/kg IV has been validated in pediatric emergency surgery when combined with neuromuscular blockade. 4

IV Administration Technique

  • Administer as a 1% solution (10 mg/mL) at a rate of approximately 1 mL every 5 seconds; higher concentrations markedly increase muscular movements and cardiorespiratory irregularities. 1

  • The induction dose typically provides 5–7 minutes of anesthesia. 1

  • Maintenance can be achieved with intermittent boluses of 20–40 mg (2–4 mL of 1% solution) every 4–7 minutes or continuous infusion of 0.2% solution at ~3 mL/minute. 1


Rectal Administration Dosing

For rectal induction, use age-adjusted dosing: 50 mg/kg for infants <6 months, 35 mg/kg for infants 6–12 months, and 25 mg/kg for children >12 months (maximum 700 mg total), administered as a 1% solution. 5, 1

Rectal Dosing Details

  • Infants <6 months: 50 mg/kg rectally as a 1% solution. 5

  • Infants 6–12 months: 35 mg/kg rectally as a 1% solution. 5

  • Children >12 months: 25 mg/kg rectally as a 1% solution, with a maximum total dose of 700 mg. 5

  • Mean induction time is rapid, and duration of deep sedation averages 60.79 ± 27 minutes, making rectal thiopental the drug of choice for pediatric sedation in neuroimaging due to rapid onset and offset. 5

  • Rectal thiopental has a significantly shorter discharge time compared to intramuscular cocktail regimens. 5


Intramuscular Administration Dosing

For IM induction, administer 6.6–10 mg/kg as a 5% solution (50 mg/mL). 1

  • The usual IM dose range is 6.6–10 mg/kg using a 5% concentration. 1

  • IM administration is less commonly used than IV or rectal routes in pediatric practice. 1


Critical Safety Considerations

Cardiovascular Depression

  • Thiopental causes significant reduction in cardiac output, stroke volume, and blood pressure through direct myocardial depression, even at standard induction doses of 7.5–8.5 mg/kg. 6

  • Premedication with atropine may ameliorate cardiac output reduction by permitting compensatory tachycardia during induction. 6

  • Intubation after thiopental induction causes hypertension and tachycardia that are not prevented by diazepam premedication. 6

Mandatory Monitoring and Rescue Capability

  • Age- and size-appropriate resuscitative equipment (intubation equipment, cardioversion, oxygen, suction, secure IV access) and qualified personnel must be immediately available before any thiopental administration. 1

  • Facilities for assisting ventilation and administering oxygen are necessary adjuncts for all routes of thiopental administration. 1

  • Cardiorespiratory arrest may occur; patients require careful observation during and after use. 1

Solution Preparation

  • Use only bacteriostatic-free diluent; Lactated Ringer's Injection is incompatible. 1

  • Preferred diluent for IV/rectal is Sterile Water for Injection; 5% Dextrose or 0.9% NaCl are acceptable alternatives. 1

  • Do not mix with acidic solutions (atropine sulfate, succinylcholine, metocurine) in the same syringe, as pH alteration precipitates free barbituric acid. 1

  • Freshly prepare solutions and use promptly; reconstituted solutions are chemically stable at room temperature for 24 hours. 1


Common Pitfalls to Avoid

  • Avoid underdosing neonates based on older pediatric dosing: Neonates require approximately half the dose of older infants (3.4 vs 6.3 mg/kg). 2

  • Do not use unpremedicated dosing in premedicated children: This results in excessive dosing and prolonged recovery; premedication reduces requirements by 50–60%. 3

  • Never administer concentrations >1% intravenously: Higher concentrations markedly increase adverse respiratory and hemodynamic effects. 1

  • Recognize that rectal midazolam is ineffective for procedural sedation: It has minimal effect compared to rectal thiopental for neuroimaging. 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.